Adverum Biotech
ADVM4.3600.00% ( 0.000 )
Q3 FY2025 Earnings
Financial report interval: 2025.06.30 - 2025.09.30
Overview: Adverum Biotech(ADVM) the EBIT is -48.02 M (-39.45%);the EPS is -2.03 (-30.92%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.05B39.45%
----
----
EPS
-2.028930.92%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf